Enteral Nutrition Market Size and Forecasts (2020 – 2030)

Enteral Nutrition Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (General and Disease Specific), Application (Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others), Age Group (Adult and Pediatric), Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPRE00004763 Category: Tags: , ,

$3,185$5,985

Description

The enteral nutrition market size is expected to grow from US$ 8.276 billion in 2022 to US$ 13.204 billion by 2030; it is estimated to grow at a CAGR of 6.0% during 2022–2030. The growth of the market is attributed to a rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral nutrition market.

Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral nutrition market growth in the future.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients’ health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products.

Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral nutrition market.

Age Group -Based Insights

Based on age group, the enteral nutrition market is categorized into adult and pediatric. In 2022, the adult segment held the largest market share. However, the pediatric segment is anticipated to record a CAGR of 6.8% during 2022–2030. A standard tube-feeding formula is designed for adults who have regular digestion. They also contain added ingredients such as fibers for better digestive health and bowel management. Like standard formulas, peptide formulas are nutritionally complete. However, unlike standard formulas, some components of peptide formulas, such as proteins, are broken down into smaller components to make them easier to digest and absorb. The easy digestibility and absorption highlight the suitability of peptide formulas in adults with digestive problems, including short bowel syndrome, inflammatory bowel disease, malabsorption, and cystic fibrosis. Specialized disease-specific enteral formulas are available for adults with special nutritional needs, such as diabetes, kidney failure, respiratory disease, or liver disorders. Several adult enteral medical nutrition formulas are available in the market. The main ingredients of medical nutritional formulas are lipid emulsions, dextrose, amino acids, vitamins, electrolytes, minerals, and trace elements. These active ingredients help prevent villous atrophy and promote the local immune function of the gut. Elecare by Ross is one of the tube-feeding formulas approved for adults. ELECARE is indicated for the dietary management of protein maldigestion, malabsorption, severe food allergies, short-bowel syndrome, and eosinophilic GI disorders, among others.

The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral nutrition market report.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

According to our latest market research study on “Global Enteral Nutrition Market Forecast to 2030 – Global Analysis – by Product Type, Application, Formula Type, Age Group, and Distribution Channel,” the market is expected to grow from US$ 8.276 billion in 2022 to US$ 13.204 billion by 2030; it is estimated to grow at a CAGR 6.8% during 2022–2030. Factors driving the market’s growth are rise in prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

Companies operating in the enteral nutrition market constantly focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below:

• In January 2023, Nutricia launched Fortimel PlantBased Energy, its first plant-based, ready-to-drink, oral nutritional supplement. The product is specifically formulated to fulfill the nutritional needs of malnourished people or people at risk of malnutrition due to illness. With the launch of Fortimel, the company builds on Danone’s (parent company) expertise in plant nutrition to expand its Fortimel portfolio. The new product is available in the Netherlands, Denmark, Norway, Spain, Finland, and the Czech Republic.

• In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC founding shareholders. The acquisition includes the GO Healthy brand. along with its vitamin and supplement lineups; the Manuka honey brand Egmont; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries.

• In May 2022, Nestle Health Science acquired Puravida, a premium Brazilian nutrition and healthy lifestyle brand. Puravida’s products complement Nestle’s portfolio. Vitamins, minerals, and supplements are part of a growing segment of Nestle. With this acquisition, the company can expand its range of brands in different categories and reach a broader range of consumers and patients with improved, reliable, nutritious, and high-quality products.

• In November 2021, Abbott launched Similac 360 Total Care with an exclusive blend of five human milk oligosaccharides (HMO). It is the US’ first and only infant formula with a blend of five different prebiotic HMOs (only found together in breast milk). Similac 360 Total Care is developed to provide nutrition to support whole health and development in babies, including the development of the immune system, digestive system, and brain.

• In September 2021, Abbott introduced plant-based protein and organic food ingredients—PediaSure Harvest and Ensure Harvest—for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements.

• In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company helps contribute to the real food blend’s mission and portfolio by bringing unique and nutritious choices to children and adults dependent on feeding tubes.

Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements, the development of innovative products targeting various health issues, and strategic moves such as expansions and acquisitions allow companies in the enteral nutrition market size to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.

A few prominent players operating in the global enteral nutrition market are Nestlé, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the global enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby’s health and development, including the developing immune system, digestive system, and brain.

Global Enteral Nutrition market, by Region, 2022 (%)

Source:the research team Analysis

The report segments the global enteral nutrition market as follows:

The enteral nutrition market, by product type, is bifurcated into general and disease-specific. The enteral nutrition market, by application, is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The enteral nutrition market, by age group, is divided into adult and pediatric. The enteral nutrition market, by distribution channel, is segmented into hospital pharmacies, retail stores, e-commerce, and others. By geography, the enteral nutrition market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Immunodiagnostics Market – by Product
1.3.2 South & Central America Immunodiagnostics Market – by Clinical Indication
1.3.3 South & Central America Immunodiagnostics Market – by End User
1.3.4 South & Central America Immunodiagnostics Market – by Country
2. South & Central America Immunodiagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Immunodiagnostics Market – Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. South & Central America Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market – South & Central America Analysis
6.1 South & Central America Immunodiagnostics Market Revenue Forecast and Analysis
7. South & Central America Immunodiagnostics Market Analysis – by Product
7.1 Overview
7.2 South & Central America Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Immunodiagnostics Market Analysis – Clinical Indication
8.1 Overview
8.2 South & Central America Immunodiagnostics Market Share by Clinical Indication – 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Immunodiagnostics Market Analysis – End User
9.1 Overview
9.2 South & Central America Immunodiagnostics Market Share by End User – 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Overview
10.1.1.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 Brazil: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.1 Brazil: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.2 Brazil: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.5 Brazil: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.1.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Argentina: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.2.3.1 Argentina: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4 Argentina: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.1 Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.2 Argentina: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.5 Argentina: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.3.3.1 Rest of South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4 Rest of South & Central America: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.1 Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.2 Rest of South & Central America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.5 Rest of South & Central America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
11. South & Central America Immunodiagnostics Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in the South & Central America immunodiagnostics market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin SpA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Enteral Nutrition Market Segmentation
Table 2. Global Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – General
Table 3. Global Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 4. North America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 5. North America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – General
Table 6. North America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 7. North America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 8. North America Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 9. North America Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 10. US Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 11. US Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 12. US Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 13. US Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 14. US Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 15. US Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 16. Canada Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 17. Canada Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 18. Canada Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 19. Canada Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 20. Canada Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 21. Canada Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 22. Mexico Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 23. Mexico Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 24. Mexico Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 25. Mexico Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 26. Mexico Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 27. Mexico Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 28. Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 29. Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 30. Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 31. Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 32. Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 33. Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 34. Germany Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 35. Germany Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 36. Germany Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 37. Germany Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 38. Germany Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 39. Germany Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 40. UK Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 41. UK Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 42. UK Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 43. UK Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 44. UK Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 45. UK Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 46. France Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 47. France Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 48. France Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 49. France Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 50. France Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 51. France Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 52. Italy Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 53. Italy Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 54. Italy Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 55. Italy Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 56. Italy Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 57. Italy Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 58. Spain Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 59. Spain Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 60. Spain Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 61. Spain Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 62. Spain Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 63. Spain Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 64. Rest of Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Product Type
Table 65. Rest of Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 66. Rest of Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 67. Rest of Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Application
Table 68. Rest of Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Age Group
Table 69. Rest of Europe Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – Distribution Channel
Table 70. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 71. Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 72. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 73. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 74. Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 75. Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 76. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 77. China Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 78. China Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 79. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 80. China Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 81. China Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 82. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 83. Japan Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 84. Japan Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 85. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 86. Japan Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 87. Japan Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 88. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 89. India Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 90. India Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 91. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 92. India Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 93. India Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 94. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 95. Australia Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 96. Australia Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 97. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 98. Australia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 99. Australia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 100. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 101. South Korea Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 102. South Korea Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 103. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 104. South Korea Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 105. South Korea Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 106. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 107. Rest of Asia Pacific Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 108. Rest of Asia Pacific Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 109. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 110. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 111. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 112. Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 113. Middle East & Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 114. Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 115. Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 116. Middle East & Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 117. Middle East & Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 118. Saudi Arabia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 119. Saudi Arabia Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 120. Saudi Arabia Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 121. Saudi Arabia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 122. Saudi Arabia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 123. Saudi Arabia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 124. South Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 125. South Africa Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 126. South Africa Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 127. South Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 128. South Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 129. South Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 130. UAE Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 131. UAE Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 132. UAE Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 133. UAE Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 134. UAE Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 135. UAE Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 136. Rest of Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 137. Rest of Middle East & Africa Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 138. Rest of Middle East & Africa Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 139. Rest of Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 140. Rest of Middle East & Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 141. Rest of Middle East & Africa Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 142. South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 143. South & Central America Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 144. South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 145. South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 146. South & Central America Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 147. South & Central America Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 148. Brazil Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 149. Brazil Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 150. Brazil Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 151. Brazil Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 152. Brazil Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 153. Brazil Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 154. Argentina Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 155. Argentina Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 156. Argentina Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 157. Argentina Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 158. Argentina Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 159. Argentina Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 160. Rest of South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 161. Rest of South & Central America Enteral Nutrition Market Revenue And Forecast To 2030 (US$ million) – General
Table 162. Rest of South & Central America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million) – Elemental Formula
Table 163. Rest of South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 164. Rest of South & Central America Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 165. Rest of South & Central America Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 166. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
Table 167. Recent Organic Growth Strategies in the Enteral Nutrition Market
Table 168. Glossary of Terms, Enteral Nutrition Market

LIST OF FIGURES

Figure 1. Enteral Nutrition Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. Enteral Nutrition Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Enteral Nutrition Market Revenue (US$ million), 2020 – 2030
Figure 6. Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 7. Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
Figure 8. General: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Disease Specific: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Gastrointestinal Disorder: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Metabolic/Inborn Errors of Metabolism: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Allergy: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Renal Disease: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Liver Disease: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Oncology: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Neurology: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
Figure 20. Adult: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pediatric: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 23. Hospital Pharmacies: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Stores: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. E-Commerce: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Enteral Nutrition Market, 2022 (US$ million)
Figure 28. North America Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 29. North America Enteral Nutrition Market, By Key Countries, 2022 And 2030 (%)
Figure 30. US Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 31. Canada Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 32. Mexico Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 33. Europe Enteral Nutrition Market, By Geography, 2022 (US$ million)
Figure 34. Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 35. Europe Enteral Nutrition Market, By Key Countries, 2022 And 2030 (%)
Figure 36. Germany Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 37. UK Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 38. France Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 39. Italy Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 40. Spain Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 41. Rest of Europe Enteral Nutrition Market Revenue And Forecast to 2030 (US$ million)
Figure 42. Enteral Nutrition Market, By Geography, 2022 (US$ Million)
Figure 43. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 44. Asia Pacific Enteral Nutrition Market, By Key Countries, 2022 And 2030 (%)
Figure 45. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 46. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 47. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 48. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 49. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 50. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 51. Enteral Nutrition Market, By Geography, 2022 And 2030 (US$ million)
Figure 52. Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 53. Middle East & Africa Enteral Nutrition Market, By Key Countries, 2022 And 2030 (%)
Figure 54. Saudi Arabia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 55. South Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 56. UAE Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 57. Rest of Middle East & Africa Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 58. Enteral Nutrition Market, By Geography, 2022 (US$ million)
Figure 59. South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 60. South & Central America Enteral Nutrition Market, By Key Countries, 2022 And 2030 (%)
Figure 61. Brazil Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 62. Argentina Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 63. Rest of South & Central America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 64. Growth Strategies in the Enteral Nutrition Market

The List of Companies – Enteral Nutrition Market
– Nestlé
– Danone S.A.
– Abbott Laboratories
– FrieslandCampina
– Fresenius SE and Co. KGaA
– B. Braun SE
– Dr. Schär AG
– Arla Food
– Reckitt Benckiser
– Perrigo Company PLC
– Fonterra Co-operative Group Limited
– Kate Farms
– Nutritional Medicinals, LLC

Reviews

There are no reviews yet.

Be the first to review “Enteral Nutrition Market Size and Forecasts (2020 – 2030)”